vamshee's blog

The hemodynamic monitoring systems market is projected to reach USD 1.14 billion in 2023, registering a Compound Annual Growth Rate (CAGR) of 6.3% during the forecast period 2024-2030. The growth of the market is majorly driven by the increasing prevalence of lifestyle diseases such as obesity, stroke, and diabetes.

View Full Report: https://www.precisionbusinessinsights.com/market-reports/global-hemodyna...

The enteral feeding devices market is projected to reach USD 3,243.71 million in 2023, registering at a Compound Annual Growth Rate (CAGR) of 5.8% during the forecast period 2024-2030. The growth of the market is majorly driven by the growing geriatric population and age-related chronic diseases.

View Full Report: https://www.precisionbusinessinsights.com/market-reports/global-enteral-...

The report "Influenza Vaccine Market by Vaccine Type (Quadrivalent and Trivalent), By Technology (Egg-based, and Cell Culture), By Age Group (Pediatric, and Adult), By Route of Administration (Injection, and Nasal Spray) - Global Forecasts to 2030", is projected to reach USD 7.32 billion in 2023, registering at a Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period 2024-2030. The growth of the influenza vaccine market is majorly driven by the rising government initiatives for spreading awareness.

The report "Continuous Glucose Monitoring Devices Market by Product (Glucose Sensors, Transmitters and Monitoring Devices, Insulin Pumps), By End User (Hospitals, Diagnostic Centres, Clinics) - Global Forecasts to 2030", is projected to reach USD 5365 million in 2023, registering at a Compound Annual Growth Rate (CAGR) of 25.2% during the forecast period 2024-2030. The growth of the continuous glucose monitoring devices market is majorly driven by the growing prevalence of diabetes.

The report "Biopsy Devices Market by Device Type (Core Biopsy Devices, Needle-Based Biopsy Devices, Vacuum-assisted Biopsy Devices, Aspiration Biopsy Needles, Other), By Application (Gastrointestinal Biopsy, Lung, Liver, Breast Biopsy, Gynaecological, Kidney, Others), By Imaging Technologies (Ultrasound-guided Biopsy, Stereotactic Guided Biopsy, CT Scan, MRI Guided Biopsy, Others), By End User (Hospitals, Clinics, Diagnostic Centres) - Global Forecasts to 2030", is projected to reach USD 2.64 billion in 2023, registering at a Compound Annual Growth Rate (CAGR) of 8.5% during the forecast pe

The report "Neuroendocrine Tumors Therapeutics Market by Drug Class (Somatostatin Analogues,(Octreotide, Lanreotide, Pasireotide), Chemotherapeutics (Fluorouracil (5-FU), Doxorubicin (Adriamycin) or liposomal doxorubicin (Doxil), Streptozocin, Temozolomide (Temodar), Capecitabine (Xeloda), Dacarbazine (DTIC), Oxaliplatin (Eloxatin)), Targeted Therapeutics, (Sunitinib, Everolimus, Others)), By Indication (Lung NET, Others NET, Gastrointestinal NET, Pancreatic NET), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others)- Global Forecasts to 2030", is projected to reach USD 1

The report "Heart Valves Market by Product Type (Replacement (Aortic, Mitral, and Others), and Repair), By Valve Type (Tissue Valve and Mechanical Valve), By Procedure (Surgical and Transcatheter), By End User (Hospitals, and Specialty Clinics & Others) - Global Forecasts to 2030", is projected to reach USD 10.28 billion in 2023, registering at a Compound Annual Growth Rate (CAGR) of 9.8% during the forecast period 2024-2030. The growth of the heart valves market is majorly driven by the increasing prevalence of valvular heart disease.

The report "Foley Catheters Market by Material (Latex, Silicone Elastomer Coated Latex, Silicone, Teflon Coated Latex, Hydrophilic Polymer Coated Latex) By Type (Indwelling catheter, Condom catheter, Intermittent catheters) By End-User (Hospitals, Nursing Homes, Home care, Clinics, Ambulatory Surgical Centres) - Global Forecasts to 2030", is projected to reach USD 1,256.2 million in 2023, registering at a Compound Annual Growth Rate (CAGR) of 6.4% during the forecast period 2024-2030.

The report "Soft Tissue Sarcoma Treatment Market by Treatment Type (Targeted Therapy, Chemotherapy, Anti-angiogenesis Drugs, Radiation Therapy, Internal Radiation Therapy, External Radiation Therapy), By Disease Type (Local Sarcoma, Regional Sarcoma, Metastatic Sarcoma), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Long-Term Care Centres) - Global Forecasts to 2030", is projected to reach USD 3,595.4 million in 2023, registering at a Compound Annual Growth Rate (CAGR) of 7.3% during the forecast period 2024-2030.

The report "Diabetic Retinopathy Market by Drug Type (Aflibercept, Ranibizumab, Corticosteroids, Others), By Route of Administration (Oral, Parenteral, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Global Forecasts to 2030", is projected to reach USD 6.24 billion in 2023, registering at a Compound Annual Growth Rate (CAGR) of 7.1% during the forecast period 2024-2030. The growth of the diabetic retinopathy market is majorly driven by the increasing technological advancements in diabetic retinopathy surgical instruments.